FDA Law Blog

OCTOBER 24, 2023

Previous iterations of this guidance from 2009 and 2014 (blogged on here and here ) were known as Good Reprint Practices (GRP). The presentation should be accompanied by the reprint and the reprint, itself, must meet the criteria articulated in the SIUU Guidance for reprints.

Clinic 64

Clinic Clinical Practice Provider Utilities 64

The Clinical Problem Solvers

DECEMBER 16, 2020

Our esteemed publications should ensure that investigations that utilize racial variables follow these guidelines before being published. Examining the Potential Impact of Race Multiplier Utilization in Estimated Glomerular Filtration Rate Calculation on African-American Care Outcomes. 2009 May;139(1):47-57. 2019;322(2):113-114.

Clinic 52

Clinic Education Clinical Practice Patient-Centered 52

FDA Law Blog

FEBRUARY 2, 2023

Alternative methods will require significant research investment to demonstrate their utility for a particular context of use and inform regulatory decision-making. For more on FDORA’s other provisions, see HPM’s complete summary here ). However, there are signs that FDA is receptive from a policy perspective to alternative methods.

Clinic 64

Clinic IT Utilities Government 64

PEMBlog

MAY 24, 2023

This entails utilizing the least invasive non-pharmacologic means of assisting them, before moving to physical or chemical restraints. 2009 Nov;27(4):655-67, ix. 2009 Jun;21(3):196-202. Patient that are agitated should always be treated with dignity and respect. Coburn VA, Mycyk MB. Physical and chemical restraints. 2009.07.003.

Management 54

Management Patient-Centered Physicals Transportation 54

GeriPal

APRIL 10, 2025

It was really at the level of the ED across 33 EDs in random order, and then tried to see if we could make a difference in healthcare utilization, primarily the primary outcome was admission to the hospital, acute care admission. Would it have changed potentially utilization rates like hospice utilization?

Patient-Centered 77

Patient-Centered IT Hospital Patients 77

GeriPal

MARCH 7, 2024

In fact, I worked for senior care options payer-provider in Massachusetts, where I am coupled end-of-life care from hospice back in 2009. it looks a little bit like VBID back in 2009, because I realized that populations are traditionally underserved and have mistrust of the healthcare system. What was the value proposition?

Provider 117

Provider Illness IT Healthcare 117